News (37)

UCB Convening Notice to the General Meeting of theShareholders 2023 AQ
UCB Convening Notice to the General Meeting of theShareholders 2023 GL
Viviane Monges to Step Down from the Board of Directors and Audit Committee of UCB SA on 27 April 2023 CI
BIC FOURTH QUARTER & FULL YEAR 2022 RESULTS GL
Transcript : Cano Health, Inc. - Analyst/Investor Day
BIC: May 18, 2022 SOCIÉTÉ BIC Annual General Meeting and Board of Directors GL
BIC : 2021 FACTSHEET PU
Transcript : Société BIC SA - Shareholder/Analyst Call
BIC: FULL YEAR 2020 RESULTS - GOVERNANCE GL
BIC : Factsheet as of 9M2020 (in english) PU
ENGIE : Analyst pack PU
CORRECTION: BIC : Q4 and Full Year 2018 Results GL
BIC : Q4 and Full Year 2018 Results GL
Nippon Paint : makes proposal to Axalta, merger talks with Akzo Nobel end RE
Akzo Nobel N.V. Announces Management Changes CI
AkzoNobel : announces new structure for Executive Committee GL
Akzo Nobel : AkzoNobel reports record profitability in Q1 2017 GL
Updated Invitation: AkzoNobel Q1 2017 results and Strategy Update webcast and press conference GL
Invitation: AkzoNobel Q1 2017 results and Strategy Update webcast and press conference GL
Akzo Nobel : Mexican capacity expansion strengthens AkzoNobel’s global organic... PU
Akzo Nobel : sales hit by weak pound RE
AkzoNobel Q3 2016 Results: Profitability increased in an environment of mixed volume growth GL
AKZO NOBEL : AkzoNobel: Growth in volumes and profitability despite challenging markets GL
AKZO NOBEL : AkzoNobel publishes Q3 2015 results PU
AKZO NOBEL : AkzoNobel Q3 2015 results - Continued increase in profitability despite challenging market conditions GL
AKZO NOBEL : AkzoNobel using new technology to recreate old masterpiece PU
AKZO NOBEL : AkzoNobel publishes Q1 2015 results GL
Euronext : EnterNext laucnhes initiative to create flexible financing solutions for the Dutch and Belgian markets PU
Euronext : expands listed private placemnet bonds offer PU
AKZO NOBEL : AkzoNobel CFO sounds gong ahead of International Women's Day PU
Akzo Nobel N.V. Appoints Maelys Castella as Member of the Board of Management CI
AKZO NOBEL : AkzoNobel EGM appoints Maëlys Castella as member of the Board of Management GL
AKZO NOBEL : Maëlys Castella appointed CFO at AkzoNobel PU
AKZO NOBEL NV : Press Release: Maëlys Castella appointed CFO at AkzoNobel GL
Press Release: Maelys Castella appointed CFO at AkzoNobel GL
AIR LIQUIDE : 2013 Results,
February 18, 2014
PU
Transcript : AtriCure, Inc., Q3 2013 Earnings Call, Oct 29, 2013

Companies (82)

PT SINAR MAS MULTIARTHA TBK 5 625 M $
Logo PT Sinar Mas Multiartha Tbk

PT Sinar Mas Multiartha Tbk is an Indonesia-based financial company engaged in financial services. It helps the organization to turn a huge amount of Big Data into real-time insight with Hadoop. It enables distributed data storage and advanced computation ...

PT DUTA PERTIWI TBK 501 M $
Logo PT Duta Pertiwi Tbk

PT Duta Pertiwi Tbk is an Indonesia-based company primarily engaged in construction business only. The Company’s segments include real estate, property, and hotel. The Company’s real estate projects include ITC Mangga Dua Shopping Center, Ruko Textil ...

PT BANK MULTIARTA SENTOSA TBK 288 M $
Logo PT Bank Multiarta Sentosa Tbk

PT Bank Multiarta Sentosa Tbk (Bank MAS) is a commercial bank. Its segments include Loans, Treasury, Trade finance, and Other. It offers a variety of financial products and facilities, ranging from savings, time deposits, ownership loans, as well as a net ...

MYSORE PETRO CHEMICALS LIMITED 14 M $
Logo Mysore Petro Chemicals Limited

Mysore Petro Chemicals Limited is engaged in the trading of organic and inorganic chemicals. The Company is involved in the trading of ortho xylene, phthalic anhydride, maleic anhydride, benzoic acid, and other petrochemical products. The Company’s Male ...

PT DIAN SWASTATIKA SENTOSA TBK 6 826 M $
Logo PT Dian Swastatika Sentosa Tbk

PT Dian Swastatika Sentosa Tbk is engaged in the business of power generation, wholesale trading, coal mining and trading, multimedia, forestry, and infrastructure. It carries out its business activities through four businesses, namely power and steam gen ...

RVL PHARMACEUTICALS PLC 11 140 $
Logo RVL Pharmaceuticals plc

RVL Pharmaceuticals plc is a specialty pharmaceutical company. The Company is focused on the commercialization of UPNEEQ, or RVL-1201 (oxymetazoline hydrochloride ophthalmic solution), 0.1%, for the treatment of acquired blepharoptosis, or low-lying eyeli ...

BRIDGE INTERNATIONAL CORP. 36 M $
Logo BRIDGE International Corp.

BRIDGE International Corp. provides comprehensive solutions services related to inside sales. The Company supports corporate sales reform through introducing inside sales which conducts sales activities by using the telephone and e-mail without visiting c ...

SOKOMAN MINERALS CORP. 8 M $
Logo Sokoman Minerals Corp.

Sokoman Minerals Corp. is a Canada-based exploration-stage company, which is focused on identifying, acquiring, and exploring mineral interests. The Company’s projects include Moosehead, Crippleback, East Alder, Iron Horse, Grey River Gold, Kepenkeck Go ...

PAZOO, INC. 2 688 $
Logo Pazoo, Inc.

Pazoo, Inc. is a health and wellness company. The Company is engaged in providing infrastructure and analytical services to legally authorized distributors and producers of organic medicines and to regulators tracking their operations. Its line of busines ...

PT NUSANTARA ALMAZIA TBK 8 M $
Logo PT Nusantara Almazia Tbk

PT Nusantara Almazia Tbk is an Indonesia-based real estate developer. The Company's operational areas are located in Karawang Regency and Tangerang City, where the Company has various residential projects located. The projects owned by the Company consist ...


1234Next

Insiders

Picture Ebbe Castella
Ebbe Castella

Ebbe Castella was a Director at Syd ABB.
A from 2013 to 2020 and an Independent Director at Alm.
Brand A from 2014 to 2020.
He also held the position of Senior Executive Vice President at Arbejdernes Landsbank AS.


Picture John Castella
John Castella

John Castella worked as Vice President-Sourcing at Jimlar Corp..
Mr. Castella attended Seton Hall University where he earned an undergraduate degree.


Picture Uilma Castella
Uilma Castella

Ms. Uilma Castella is a Portfolio Manager at Octogone Family Office SA. She has over 25 years of experience in the financial markets.
Before joining Octogone Gestion, she worked as Portfolio Manager for Sartus Capital in Geneva.
Before that, she worked as a Senior Relationship Manager at BNP Paribas.
Before that, she worked for HSBC Private Bank (Suisse) SA. Before that, she worked at Merrill Lynch Private Bank (Suisse) SA. She started her career in Switzerland at American Express in Geneva.
She graduated with a bachelor's degree in finance and accounting in Brazil.




Picture Jean-François Castella
Jean-François Castella

Jean-François Castella has worked as a Director at Infotel Corp.
and as a Vice President-Software at Infotel SA.



Picture Maëlys Castella
Maëlys Castella

Maëlys Castella is the founder of AminonaConsulting BV.
She currently holds positions as an Independent Director at Société BIC SA, UCB SA, BIC USA, Inc., and C&A Europe SA. Her former positions include Director at Akzonobel Art Foundation, Chief Financial Officer at Akzo Nobel NV, Group Deputy Chief Financial Officer at Air Liquide Finland Oy and Air Liquide BV, and Head-Investor Relations & Controller at Elf Group Ltd.
She has also served as Chief Financial Officer at Akzo Nobel Ltda.
Castella has a graduate degree from the University of Pennsylvania, an undergraduate degree from École Centrale Paris, and a graduate degree from IFP School.


Picture Paul Castella
Paul Castella

Paul Castella is the founder of Bio2 Medical, Inc. (founded in 2006) where he holds the title of Director.
He is also the founder of ViroXis Corp.
(founded in 2006) and Aeon Bioscience, Inc. (founded in 2007) where he holds the titles of Director and Chief Business Officer respectively.
In 2020, he founded Hera Biotech, Inc. where he currently serves as Chairman.
Dr. Castella is also the founder of Targeted Technology Ventures LLC.
Currently, Dr. Castella holds positions as Chairman at BioDtech, Inc., Director at StemBioSys, Inc., Director at Innovative Trauma Care, Inc., Director at CytoBioscience, Inc., and Senior Managing Partner at Incyte Venture Partners LLC (since 2013).
Dr. Castella's former positions include Chief Executive Officer & Director at InventaBiotech, Inc. and President & Chief Financial Officer at CardioSpectra, Inc.Dr. Castella's education includes an undergraduate degree from the University of London (1987), an MBA from The University of Texas at Austin (2005), and a doctorate from Weill Cornell Medical College.


No results for this search